bay x 1005 has been researched along with cysteine in 2 studies
Studies (bay x 1005) | Trials (bay x 1005) | Recent Studies (post-2010) (bay x 1005) | Studies (cysteine) | Trials (cysteine) | Recent Studies (post-2010) (cysteine) |
---|---|---|---|---|---|
58 | 6 | 8 | 40,132 | 418 | 11,457 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berti, F; Buccellati, C; Folco, GC; Maclouf, J; Molta, C; Muller-Peddinghaus, R; Rossoni, G; Sala, A; Testa, T | 1 |
Berti, F; Folco, G; Müller-Peddinghaus, R; Rossoni, G; Sala, A | 1 |
2 other study(ies) available for bay x 1005 and cysteine
Article | Year |
---|---|
Myocardial protection by the leukotriene synthesis inhibitor BAY X1005: importance of transcellular biosynthesis of cysteinyl-leukotrienes.
Topics: Animals; Arachidonate 5-Lipoxygenase; Calcimycin; Coronary Vessels; Creatine Kinase; Cysteine; Electrocardiography; Endothelium, Vascular; Enzyme Activation; Heart; Heart Diseases; Humans; In Vitro Techniques; L-Lactate Dehydrogenase; Leukotrienes; Lipoxygenase Inhibitors; Male; Myocardial Ischemia; Myocardium; Neutrophils; Peroxidase; Quinolines; Rabbits | 1996 |
Transcellular synthesis of Cys-LT: from isolated cells to complex organ system.
Topics: Animals; Arachidonate 5-Lipoxygenase; Calcimycin; Cardiotonic Agents; Coronary Vessels; Cysteine; Heart; Humans; In Vitro Techniques; Leukotrienes; Lipoxygenase Inhibitors; Male; Neutrophils; Perfusion; Quinolines; Rabbits; Ventricular Function, Left | 1997 |